Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • nouse
    Member
    • Sep 2013
    • 11

    #1

    Normalization for NGS count data with high variance between observations / uneven com

    Dear community,

    we have a MiSeq 16S-dataset featuring samples from enrichment studies, i.e. communities from a time series in which some OTUs become dominant over time, e.g. up to 90% of all reads. The biological question would to find a) which OTUs respond to different enrichment strategies and b) when they start to enrich. I guess, this qualifies as a expression analysis to detect differentially expressed OTUs.

    Thus, we need to normalize the data due to highly variable sequence depths (20,000 to 70, 000 reads) and to validate our post-hoc analysis.

    I tried percentile-based normalization like CSS but i have just learned the hard way, that they are not suited for this dataset (as they typically want to see relatively invariate data). CSS, e.g., just took away all observations from the enriched OTUs until the enrichment effect was not visible anymore.

    Rarefying is inadmissable as McMurdie & Holmes told us.

    Total-Sum-Scaling (i.e. scaling to all reads in a sample) is dangerous because it is sensitive to compositional effects (as our samples tend to become very uneven over time).

    Any ideas how to best treat the data would be greatly appreciated.

    I posted the same question to the QIIME and Biostars forums, but got few answers which sums up to "There is no real answer to your problem".

    I was pointed to ANCOM (and texmexseq), which are nice tools, but they either dont say anything about normalization or do it internally.

Latest Articles

Collapse

  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Today, 02:55 AM
0 responses
6 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
11 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-23-2026, 11:41 AM
0 responses
12 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-20-2026, 11:10 AM
0 responses
24 views
0 reactions
Last Post SEQadmin2  
Working...